Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients

Background and objectives: This study aimed to assess the clinical significance of serum cystatin C in the early diagnosis of renal injury and its association with dyslipidemia in young T1D patients. Materials and Methods: A total of 779 subjects were evaluated for kidney function by estimating glom...

Descripción completa

Detalles Bibliográficos
Autores principales: Stankute, Ingrida, Radzeviciene, Lina, Monstaviciene, Ausra, Dobrovolskiene, Rimante, Danyte, Evalda, Verkauskiene, Rasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878987/
https://www.ncbi.nlm.nih.gov/pubmed/35208542
http://dx.doi.org/10.3390/medicina58020218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878987/
https://www.ncbi.nlm.nih.gov/pubmed/35208542
http://dx.doi.org/10.3390/medicina58020218

Ejemplares similares